Table 4

Number of days, severity and type of COVID-19 symptoms in association with access to personal protective equipment (PPE) in exposed healthcare workers

OR access to PPE good versus excellentOR access to PPE
basic versus excellent
OR access to PPE poor versus excellentP trend
>14 days of symptoms1.26 (0.62–2.55)1.76 (0.86–3.61)2.39 (1.10–5.22)0.0044
Moderate to severe symptoms1.70 (0.90–3.20)1.63 (0.83–3.19)3.51 (1.70–7.26)0.0058
Specific COVID-19 symptoms:
Fatigue and muscle aches1.53 (0.79–2.93)2.07 (1.00–4.30)0.97 (0.46–2.08)0.86
Loss of taste or smell1.17 (0.66–2.09)1.74 (0.95–3.18)1.31 (0.67–2.58)0.46
Cough1.46 (0.85–2.51)1.59 (0.90–2.81)1.48 (0.78–2.79)0.36
Diarrhoea1.88 (0.94–3.73)2.04 (1.01–4.12)1.79 (0.82–3.89)0.28
Nausea or vomiting1.18 (0.53–2.64)2.53 (1.14–5.59)2.10 (0.87–5.07)0.029
Sore throat or headache2.40 (1.37–4.18)2.92 (1.62–5.27)2.15 (1.11–4.14)0.039
Fever or chills1.47 (0.85–2.56)1.49 (0.83–2.65)2.25 (1.16–4.39)0.049
Shortness of breath or difficulty breathing1.10 (0.60–2.03)1.46 (0.78–2.76)2.45 (1.22–4.93)0.021
Respiratory symptoms: abnormal chest X-ray, low oxygen saturation (SpO2) <93%) at rest, respiratory distress, respiratory rate ≥30 times/min, or acute lung injury1.48 (0.43–5.09)1.74 (0.48–6.30)3.33 (0.93–11.86)0.036
  • *Adjusted for age, gender, country, diabetes, pre-diabetes, coronary artery disease, overweight, asthma and high-risk exposure to an individual with COVID-19 outside of the workplace (n=568 total).

  • †Poor access to PPE was described as ‘little access to masks, face shields, gowns, and gloves’. Basic access was described as ‘access to at least one daily mask, face shield, gown, and gloves’. Good access to PPE was described as ‘I had access to a change of mask, gown, and gloves if soiled as well as a face shield’. Excellent access to PPE was described as ‘I had access to a fresh mask, gown, and gloves every time that I entered a new patient room as well as a face shield’.